As an athlete, Amy Dixon is used to overcoming adversity.She is a member of the U.S. Paratriathlon team and has competed in eight world championships and the Tokyo 2020 Paralympic Games. When she was 22 years old, she was diagnosed with multifocal chor…
Ray Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RTx-015 in Retinitis Pigmentosa
BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics (RayTx), a clinical-stage biopharmaceutical company pioneering optogenetic therapies for those living with retinal degenerative diseases, today announced that the U.S. Food and Drug Administration (FD…
Amprion Grows Global Footprint with Australian Partnership & Expanded Research Collaborations
SAN FRANCISCO–(BUSINESS WIRE)–Amprion Grows Global Footprint with Australian Partnership & Expanded Research Collaborations
Haag-Streit launches Metis 3D Digital Heads-Up Module worldwide
The Metis 3D Digital Heads-Up Module from Haag-Streit is now available worldwide, according to a press release.The device, which debuted at the American Academy of Ophthalmology meeting in October 2025, expands on the company’s Metis 900 microscope wit…
Yuvezzi for presbyopia now available in US
Editor’s note: This is a developing story. Please check back soon for updates.Yuvezzi, an eye drop for the treatment of presbyopia, is now available in the U.S.According to a press release from Tenpoint Therapeutics, patients can fill prescriptions fro…
Biogen to acquire Apellis for $5.6 billion
Editor’s note: This is a developing story. Please check back soon for updates.Under the terms of a definitive agreement, Biogen will acquire Apellis for $41 per share in cash, or approximately $5.6 billion, according to a press release from Biogen.The …